Tina Ventura | VP, IR |
Tim Walbert | Chairman, President and CEO |
Shao-Lee Lin | EVP, Head R&D and Chief Scientific Officer |
Paul Hoelscher | EVP and CFO |
Bob Carey | EVP and Chief Business Officer |
Vikram Karnani | EVP and Chief Commercial Officer |
Annabel Samimy | Stifel, Nicolaus & Company, Inc. |
David Amsellem | Piper Jaffray |
David Risinger | Morgan Stanley |
Stacy Ku | Cowen & Company |
David Steinberg | Jefferies |
Don Ellis | JMP Securities |
Louise Chen | Cantor |
Gary Nachman | BMO Capital Markets |
Good morning and thank you for standing by. Welcome to the Horizon Therapeutics PLC Second Quarter 2019 Earnings Conference Call.
As a reminder, today's conference call is being recorded.
I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.